|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2018. CA Cancer J Clin. 68:7–30. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cao L, Lee CH, Ning J, Handy BC, Wagar EA
and Meng QH: Combination of prostate cancer antigen 3 and
prostate-specific antigen improves diagnostic accuracy in men at
risk of prostate cancer. Arch Pathol Lab Med. 14:1106–1112. 2018.
View Article : Google Scholar
|
|
3
|
Nordström T, Akre O, Aly M, Grönberg H and
Eklund M: Prostate-Specific antigen (PSA) density in the diagnostic
algorithm of prostate cancer. Prostate Cancer Prostatic Dis.
21:57–63. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chunhua L, Zhao H, Zhao H, Lu Y, Wu J, Gao
Z, Li G, Zhang Y and Wang K: Clinical significance of peripheral
blood PCA3 gene expression in early diagnosis of prostate cancer.
Transl Oncol. 11:628–632. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bradshaw AD and Sage EH: SPARC, a
matricellular protein that functions in cellular differentiation
and tissue response to injury. J Clin Invest. 107:1049–1054. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ma LJ, Wu WJ, Wang YH, Wu TF, Liang PI,
Chang IW, He HL and Li CF: SPOCK1 overexpression confers a poor
prognosis in urothelial carcinoma. J Cancer. 7:467–476. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Dhamija R, Graham JM Jr, Smaoui N,
Thorland E and Kirmani S: Novel de novo SPOCK1 mutation in a
proband with developmental delay, microcephaly and agenesis of
corpus callosum. Eur J Med Genet. 57:181–184. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Song X, Han P, Liu J, Wang Y, Li D, He J,
Gong J, Li M, Tu W, Yan W, et al: Up-Regulation of SPOCK1 induces
epithelial-mesenchymal transition and promotes migration and
invasion in esophageal squamous cell carcinoma. J Mol Histol.
46:347–356. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li Y, Chen L, Chan TH, Liu M, Kong KL, Qiu
JL, Li Y, Yuan YF and Guan XY: SPOCK1 is regulated by CHD1L and
blocks apoptosis and promotes HCC cell invasiveness and metastasis
in mice. Gastroenterology. 144:179–191. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Colin C, Baeza N, Bartoli C, Fina F, Eudes
N, Nanni I, Martin PM, Ouafik L and Figarella-Branger D:
Identification of genes differentially expressed in glioblastoma
versus pilocytic astrocytoma using suppression subtractive
hybridization. Oncogene. 25:2818–2826. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Miao L, Wang Y, Xia H, Yao C, Cai H and
Song Y: SPOCK1 is a novel transforming growth factor-beta target
gene that regulates lung cancer cell epithelial-mesenchymal
transition. Biochem Biophys Res Commun. 440:792–797. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen Q, Yao YT, Xu H, Chen YB, Gu M, Cai
ZK and Wang Z: SPOCK1 promotes tumor growth and metastasis in human
prostate cancer. Drug Des Devel Ther. 10:2311–2321. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yang C, Fischer-Kešo R, Schlechter T,
Ströbel P, Marx A and Hofmann I: Plakophilin 1-deficient cells
upregulate SPOCK1: Implications for prostate cancer progression.
Tumour Biol. 36:9567–9577. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Torrini C, Cubero RJ, Dirkx E, Braga L,
Ali H, Prosdocimo G, Gutierrez MI, Collesi C, Licastro D, Zentilin
L, et al: Common regulatory pathways mediate activity of MicroRNAs
inducing cardiomyocyte proliferation. Cell Rep. 27:2759–2771. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li H, Xie S, Liu M, Chen Z, Liu X, Wang L,
Li D and Zhou Y: The clinical significance of downregulation of
mir-124-3p, mir-146a-5p, mir-155-5p and mir-335-5p in gastric
cancer tumorigenesis. Int J Oncol. 45:197–208. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li S, Zhang T, Zhou X, Du Z, Chen F, Luo J
and Liu Q: The tumor suppressor role of miR-155-5p in gastric
cancer: The tumor suppressor role of miR-155-5p in gastric cancer.
Oncol Lett. 16:2709–2714. 2018.PubMed/NCBI
|
|
17
|
Lin J, Chen Y, Liu L, Shen A and Zheng W:
MicroRNA-155-5p suppresses the migration and invasion of lung
adenocarcinoma A549 cells by targeting smad2. Oncol Lett.
16:2444–2452. 2018.PubMed/NCBI
|
|
18
|
Qu YL, Wang HF, Sun ZQ, Tang Y, Han XN, Yu
XB and Liu K: Up-Regulated miR-155-5p promotes cell proliferation,
invasion and metastasis in colorectal carcinoma. Int J Clin Exp
Pathol. 8:6988–6994. 2015.PubMed/NCBI
|
|
19
|
Bhattacharya S, Chalk AM, Ng AJ, Martin
TJ, Zannettino AC, Purton LE, Lu J, Baker EK and Walkley CR:
Increased miR-155-5p and reduced miR-148a-3p contribute to the
suppression of osteosarcoma cell death. Oncogene. 35:5282–5294.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kim H, Yang JM, Ahn SH, Jeong WJ, Chung JH
and Paik JH: Potential oncogenic role and prognostic implication of
microRNA-155-5p in oral squamous cell carcinoma. Anticancer Res.
38:5193–5200. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liu YZ, Guo YF, Wang L, Tan LJ, Liu XG,
Pei YF, Yan H, Xiong DH, Deng FY, Yu N, et al: Genome-Wide
association analyses identify SPOCK as a key novel gene underlying
age at menarche. PLoS Genet. 5:e10004202009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Daniunaite K, Dubikaityte M, Gibas P,
Bakavicius A, Lazutka JR, Ulys A, Jankevicius F and Jarmalaite S:
Clinical significance of miRNA host gene promoter methylation in
prostate cancer. Hum Mol Genet. 26:2451–2461. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang L, Liu Y, Chen XG, Zhang Y, Chen J,
Hao ZY, Fan S, Zhang LG, Du HX and Liang CZ: MicroRNA expression
profile in chronic nonbacterial prostatitis revealed by
next-generation small RNA sequencing. Asian J Androl. 21:351–359.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chen WY, Tsai YC, Yeh HL, Suau F, Jiang
KC, Shao AN, Huang J and Liu YN: Loss of SPDEF and gain of TGFBI
activity after androgen deprivation therapy promote EMT and bone
metastasis of prostate cancer. Sci Signal. 10:4922017. View Article : Google Scholar
|
|
26
|
Huber MA, Azoitei N, Baumann B, Grünert S,
Sommer A, Pehamberger H, Kraut N, Beug H and Wirth T: NF-kappaB is
essential for epithelial-mesenchymal transition and metastasis in a
model of breast cancer progression. J Clin Invest. 114:569–581.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yang H, Liang J, Zhou J, Mi J, Ma K, Fan
Y, Ning J, Wang C, Wei X and Li E: Knockdown of RHOC by shRNA
suppresses invasion and migration of cholangiocellular carcinoma
cells via inhibition of MMP2, MMP3, MMP9 and epithelial-mesenchymal
transition. Mol Med Rep. 13:5255–5261. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chen L, Mai W, Chen M, Hu J, Zhuo Z, Lei
X, Deng L, Liu J, Yao N, Huang M, et al: Arenobufagin inhibits
prostate cancer epithelial-mesenchymal transition and metastasis by
down-regulating β-catenin. Pharmacol Res. 123:130–142. 2017.
View Article : Google Scholar : PubMed/NCBI
|
